WallStreetZenWallStreetZen

NASDAQ: SLN
Silence Therapeutics PLC Stock Ownership - Who owns Silence Therapeutics?

Insider buying vs selling

Have Silence Therapeutics PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLN insiders and whales buy or sell their stock.

SLN Shareholders

What type of owners hold Silence Therapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Lombard Odier Asset Management Usa Corp3.26%3,879,173$86.39MInstitution
Lombard Odier Asset Management Europe Ltd3.04%3,612,877$80.46MInstitution
Artal Group Sa2.52%3,000,000$66.81MInstitution
Tcg Crossover Management LLC1.77%2,104,875$46.88MInstitution
Deep Track Capital LP1.64%1,951,580$43.46MInstitution
Bvf Inc1.27%1,508,416$33.59MInstitution
Aquilo Capital Management LLC0.88%1,043,284$23.23MInstitution
Frazier Life Sciences Management LP0.74%881,173$19.62MInstitution
Vivo Capital LLC0.43%510,204$11.36MInstitution
Logos Global Management LP0.34%400,000$8.91MInstitution

1 of 3

SLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLN17.28%0.00%
BCRX83.05%16.95%Net SellingNet Selling
IMNM36.00%9.90%Net Buying
ALXO75.63%24.37%Net SellingNet Selling
ARQT73.15%26.85%Net BuyingNet Selling

Silence Therapeutics Stock Ownership FAQ

Who owns Silence Therapeutics?

Silence Therapeutics (NASDAQ: SLN) is owned by 17.28% institutional shareholders, 0.00% Silence Therapeutics insiders, and 82.72% retail investors. Lombard Odier Asset Management Usa Corp is the largest individual Silence Therapeutics shareholder, owning 3.88M shares representing 3.26% of the company. Lombard Odier Asset Management Usa Corp's Silence Therapeutics shares are currently valued at $83.87M.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.